Kestra Medical Technologies, Ltd. (KMTS)

Market Cap	1.23B +41.1%
Revenue (ttm)	95.13M +59.0%
Net Income	-131.61M
EPS	-2.43
Shares Out	58.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	176,375
Open	21.90
Previous Close	21.57
Day's Range	20.89 - 21.92
52-Week Range	14.10 - 30.00
Beta	n/a
Analysts	Strong Buy
Price Target	30.00 (+42.45%)
Earnings Date	Jul 14, 2026

About KMTS

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. Its platform provides ASSURE Wearable Cardioverte...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Mar 6, 2025
• Employees: 443
• Stock Exchange: NASDAQ
• Ticker Symbol: KMTS
• Website: https://kestramedical.com

Financial Performance

In fiscal year 2026, KMTS's revenue was $95.13 million, an increase of 59.03% compared to the previous year's $59.82 million. Losses were -$131.61 million, 4.34% more than in 2025.

Analyst Summary

According to 7 analysts, the average rating for KMTS stock is "Strong Buy." The 12-month stock price target is $30.0, which is an increase of 42.45% from the latest price.

Price Target

$30.0

(42.45% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Jul 25, 2026

Data Sources Report a data error